Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2008-04-08 (18 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MARSEILLE (13014), Bouches-du-Rhone
SELARL PHARMACIE CAZENAVE : revenue, balance sheet and financial ratios
SELARL PHARMACIE CAZENAVE is a French company
founded 18 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MARSEILLE (13014),
this company of category PME
shows in 2017 a revenue of 1.0 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE CAZENAVE (SIREN 503776601)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
1 047 821 €
1 055 312 €
1 010 403 €
Net income
-34 739 €
-11 394 €
91 166 €
180 855 €
53 721 €
66 644 €
95 430 €
80 105 €
107 598 €
75 509 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
113 393 €
150 106 €
105 559 €
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
7.6%
10.2%
7.5%
Revenue and income statement
In 2024, SELARL PHARMACIE CAZENAVE records a net loss of 35 k€. This deficit will reduce equity on the balance sheet.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
-34 739 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 2%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 89%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
1.815%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
89.082%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
84.072
56.459
39.428
22.925
11.773
7.859
3.176
2.422
1.735
1.815
Financial autonomy
48.763
55.527
63.267
72.892
81.88
83.81
84.931
87.613
87.408
89.082
Repayment capacity
5.743
3.606
3.305
None
None
None
None
None
None
None
Cash flow / Revenue
8.393%
10.183%
8.708%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
1.812024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Excellent
In 2024, the debt ratio of SELARL PHARMACIE CAZENAVE (1.81) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
89.08%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent+12 pts over 3 years
In 2024, the financial autonomy of SELARL PHARMACIE CAZENAVE (89.1%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 189.63. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
141.751
139.657
139.488
143.141
116.264
150.063
199.756
224.019
205.747
189.628
Interest coverage
9.797
4.795
4.972
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
189.632024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Good-6 pts over 3 years
In 2024, the liquidity ratio of SELARL PHARMACIE CAZENAVE (189.63) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE CAZENAVE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
114 418 €
79 950 €
101 020 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
31
30
29
0
0
0
0
0
0
0
Customer payment term (days)
12
8
7
0
0
0
0
0
0
0
Supplier payment term (days)
45
54
50
0
0
0
0
0
0
0
Positioning of SELARL PHARMACIE CAZENAVE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE CAZENAVE with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE CAZENAVE
What is the revenue of SELARL PHARMACIE CAZENAVE ?
The revenue of SELARL PHARMACIE CAZENAVE in 2017 is 1.0 M€.
Is SELARL PHARMACIE CAZENAVE profitable?
SELARL PHARMACIE CAZENAVE recorded a net loss in 2024.
Where is the headquarters of SELARL PHARMACIE CAZENAVE ?
The headquarters of SELARL PHARMACIE CAZENAVE is located in MARSEILLE (13014), in the department Bouches-du-Rhone.
Where to find the tax return of SELARL PHARMACIE CAZENAVE ?
The tax return of SELARL PHARMACIE CAZENAVE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE CAZENAVE operate?
SELARL PHARMACIE CAZENAVE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart